Nuclear Syndecan-1 Regulates Epithelial-Mesenchymal Plasticity in Tumor Cells.
Ontology highlight
ABSTRACT: Tumor cells undergoing epithelial-mesenchymal transition (EMT) lose cell surface adhesion molecules and gain invasive and metastatic properties. EMT is a plastic process and tumor cells may shift between different epithelial-mesenchymal states during metastasis. However, how this is regulated is not fully understood. Syndecan-1 (SDC1) is the major cell surface proteoglycan in epithelial cells and has been shown to regulate carcinoma progression and EMT. Recently, it was discovered that SDC1 translocates into the cell nucleus in certain tumor cells. Nuclear SDC1 inhibits cell proliferation, but whether nuclear SDC1 contributes to the regulation of EMT is not clear. Here, we report that loss of nuclear SDC1 is associated with cellular elongation and an E-cadherin-to-N-cadherin switch during
SUBMITTER: Kumar-Singh A
PROVIDER: S-EPMC8230654 | biostudies-literature | 2021 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA